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Coronary heart disease is a major cause of death and 
disability in developed countries. Coronary artery 
bypass grafting (CABG) remains the most effective 
way of treatment for patients with advanced disease (1). 
Approximately one million people undergo CABG annually 
worldwide, depicting the epidemiologic impact of the 
procedure and its influence on public health. Continuous 
efforts are employed to optimize the procedure of CABG. 
Long-term results depend highly on the appropriate 
conduit choice for bypass. Several groups support the 
use of multiple arterial grafts for improving long-term 
outcomes. Others claim a lack of unequivocal evidence that 
this strategy is associated with better clinical outcome and 
higher patency rates. The most widespread combination of 
grafts for CABG remains the left internal thoracic artery to 
the left anterior descending coronary artery supplemented 
with multiple venous grafts for remaining territories (2). 
However, relative to arterial grafts, saphenous vein graft 
failure rates were reported high, at up to 25% in the first 18 
months (3). 
Both radial and right internal thoracic artery grafts have 
been investigated and generally show better patency than 
saphenous-vein grafts. However, they are not routinely 
used due to the complexity of CABG with multiple arterial 
grafts. The use of a left internal thoracic artery graft to the 
left anterior descending coronary artery is considered a 
major quality indicator in CABG and the associated clinical 
outcomes are better than those of patients with no left 
internal thoracic artery graft (4). The excellent long-term 
results of the left internal thoracic artery have motivated 
surgeons to use both internal thoracic arteries. However, 
randomized trial data of a potential survival benefit with 
the bilateral internal thoracic artery approach is lacking 
(5,6). Also, it is a more complex procedure, associated 
with a higher risk of sternal wound complications (5). On 
the other hand, radial artery grafts are being increasingly 
used. While long-term patency of the radial artery has 
been established (7), the clinical benefit of the radial artery 
reported in observational studies has not been confirmed in 
a randomized clinical trial (8). 
Patient selection is crucial for achieving excellent long-
term results with the radial artery. Harvesting of the radial 
artery a priori requires evaluation for adequate ulnar artery 
flow. If ulnar artery flow is inadequate the radial artery 
should not be used in order to prevent the loss of hand 
function. Target vessel stenosis and run-off are key factors 
that determine radial artery patency. General agreement is 
that the radial artery should only be used to bypass target 
vessels with highly significant stenosis (9). Target vessel 
stenosis of >70% on the circumflex territory and >90% 
on the right coronary territory are considered suitable 
for bypassing with the radial artery. Surgeons are often 
Editorial
No-touch saphenous vein as an important conduit of choice in 
coronary bypass surgery
Tomislav Kopjar1, Michael Richard Dashwood2, Mats Dreifaldt3, Domingos Ramos de Souza3
1Department of Cardiac Surgery, University Hospital Centre Zagreb, Zagreb, Croatia; 2Surgical and Interventional Sciences, Royal Free Hospital 
Campus, University College Medical School, London, UK; 3Department of Cardiothoracic and Vascular Surgery, Faculty of Medicine and Health, 
Örebro University, Örebro, Sweden
Correspondence to: Tomislav Kopjar, MD, PhD. Department of Cardiac Surgery, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, 
Croatia. Email: tkopjar@gmail.com.
Provenance: This is an invited Editorial commissioned by the Section Editor Dr. Kui Hu (Department of Cardiovascular Surgery, Guizhou Provincial 
People’s Hospital, Guiyang, China).
Comment on: Gaudino M, Benedetto U, Fremes S, et al. Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery. N Engl J Med 
2018;378:2069-77. 
Submitted Aug 16, 2018. Accepted for publication Aug 23, 2018.
doi: 10.21037/jtd.2018.08.127
View this article at: http://dx.doi.org/10.21037/jtd.2018.08.127
3296
S3293Journal of Thoracic Disease, Vol 10, Suppl 26 September 2018
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2018;10(Suppl 26):S3292-S3296jtd.amegroups.com
confronted with borderline flow limiting stenosis where the 
radial artery was shown not to be effective. Contemporary 
practice entails increasingly difficult cases, older, obese and 
diabetic patients and those with small vessels and diffuse 
disease. In such cases performing sequential grafts seems to 
be the solution. Among all of the grafts used in CABG the 
radial artery is particularly prone to spasm, possibly because 
of its large medial cross-sectional area. Spasm has been 
reported to occur in 4–10% of radial grafts immediately 
after surgery (10). When the radial artery is used for CABG 
calcium channel blockers are needed to prevent spasm. 
Radial artery grafts should be avoided in patients with 
chronic renal disease, since harvesting of a radial artery 
in such patients precludes use of the ipsilateral arm for 
vascular access in case of later onset hemodialysis. 
In a recent issue of The New England Journal of Medicine, 
the RADIAL (Radial Artery Database International 
ALliance) group provide evidence supporting the 
superiority of the radial artery when compared to the 
saphenous vein as a conduit of second choice in CABG (11). 
The authors performed a patient-level combined analysis to 
overcome the power limitations of individual underpowered 
studies. After performing a systematic literature search, 
they include six randomized controlled trials that compare 
clinical outcome and angiographic patency of the two 
grafts in CABG. By pooling the data from the six trials 
1,036 patients were analyzed. The primary outcome was a 
composite of major adverse cardiac events during follow-
up and included death, myocardial infarction, and repeat 
revascularization. The secondary outcome was graft patency 
at the protocol-defined follow-up angiography. After a 
mean follow-up of 5 years, the use of radial artery grafts 
was associated with a lower composite outcome of death, 
myocardial infarction, or repeat revascularization (hazard 
ratio 0.67; 95% confidence interval, 0.49–0.90, P=0.01) and 
with lower risk of two individual components, myocardial 
infarction and repeat revascularization, but not death from 
any cause. The use of radial-artery grafts was also associated 
with higher rates of angiographic patency.
In spite of the excellent long-term angiographic results 
of the radial artery the need to improve the quality of 
saphenous vein grafts persists. The saphenous vein is still 
used in over 90% of CABG cases (2). Several attempts 
for improving the quality of saphenous vein grafts have 
been made. The ‘no-touch’ saphenous vein harvesting 
technique dramatically improves the long-term patency of 
saphenous vein grafts. Most of the studies that compared 
the saphenous vein to the radial artery patency employed 
the harvesting technique as originally described by Favaloro 
50 years ago. Unlike the conventional technique, the ‘no-
touch’ technique of saphenous vein harvesting leaves a 
pedicle of perivascular tissue intact, preserves the outer 
layers of the vessel wall, and obviates the need for graft 
distension (12). This technique improved long-term 
saphenous vein patency (13,14). The veins harvested using 
the ‘no-touch’ technique (Figure 1) have a patency rate of 
Figure 1 Examples of ‘no-touch’ (left) and conventional (right) saphenous vein explants and representative transverse sections stained for 
collagen. The reduction in vascular damage and preservation of various cells and structures have been proposed to contribute to the superior 
patency of no-touch saphenous vein grafts [modified with permission from (15)].
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83% at 16 years (16), while conventional saphenous vein 
grafts fail at a rate as high as 25% in the first 18 months (3). 
It has also been suggested that in elderly patients with 
multiple comorbidities the ‘no-touch’ saphenous graft 
could be used as a promising substitute for the left internal 
thoracic artery (17).
Some limitations of the graft patency analysis in the 
study by the RADIAL group need to be mentioned here (11). 
Due to absence of per-protocol angiography in one and 
within patient randomization in another trial, only four out 
of six trials were included in the main graft patency analysis. 
A total of 345 of 434 patients (79%) in the radial artery 
and 307 of 402 patients (76%) in the saphenous vein group 
underwent protocol defined angiography. A comparison of 
the baseline characteristics between patients with follow-
up angiographic data and those without revealed significant 
baseline differences for age, sex, left ventricular ejection 
fraction, and target vessel revascularization. The mean 
follow-up time to protocol angiography was 50±30 months, 
with a range spanning from 1 to 143 months. Events of 
graft occlusion per 1,000 patient-years showed that the 
radial-artery grafts were associated with a significantly 
lower risk of occlusion (19 vs. 46; hazard ratio 0.44; 95% 
confidence interval, 0.28–0.70, P<0.001). Supplementary 
Appendix provides angiographic results by trial for five 
trials with protocol-driven angiography and overall, again 
revealing significantly lower risk of radial artery graft 
occlusion (10% vs. 19%; hazard ratio 0.46; 95% confidence 
interval, 0.31–0.69, P<0.001). The Örebro group compared 
the ‘no-touch’ saphenous vein and the radial artery patency 
in a controlled, randomized trial (18). This trial revealed 
that the ‘no-touch’ saphenous vein had a superior patency 
than the radial artery after 3-year follow-up. In spite of 
conducting a thorough literature search for publications 
comparing radial artery and saphenous vein grafts in CABG 
the study from the Örebro group, published in 2013 in 
The Annals of Thoracic Surgery (18), was not included in the 
analysis by the RADIAL group (11). Interestingly, if the 
angiographic patency data of the five trials with protocol-
driven angiography were supplemented with the data from 
the Örebro group the difference in risk of graft occlusion 
between the radial artery and saphenous vein grafts 
dissipates (11% vs. 18%, risk ratio 0.72; 95% confidence 
interval, 0.35–1.45, P=0.35, I2=73%, Figure 2). The study by 
Song and colleagues, which was included in the RADIAL 
group analysis, employed the ‘no-touch’ harvesting 
technique per protocol (19). Out of the six trials included in 
the analysis, only this trial had numerically lower patency of 
the radial artery than the saphenous vein (11).
Intraoperative graft handling is of utmost importance for 
long-term graft quality, not only for saphenous vein but also 
for arterial grafts. The radial artery was introduced in the 
70s, although it was soon abandoned because of early graft 
failure (20). After some modifications in practice (refined 
harvesting, routine calcium channel blocker administration, 
and careful choice of coronary targets) the radial artery 
was reintroduced in the 90s. Better understanding of radial 
artery biology was important for the improved results 
Figure 2 Forest plot of comparison: saphenous vein vs. radial artery patency. Data pooling was based on six randomized controlled trials 
with protocol-driven angiography comparing saphenous vein and radial artery patency. Five out of six trials (RAPCO, RAPS, RSVP, Song 
et al., and Stand-in-Y) were included in the graft patency analysis by Gaudino et al. (11). Remaining trial (Dreifaldt et al.), published by the 
Örebro group, compared ‘no-touch’ saphenous vein and radial artery patency (18). Pooled risk ratio effect measure was calculated with 
a random-effect model using Mantel-Haenszel statistical method. No significant difference in risk of graft failure was observed between 
saphenous vein and radial artery grafts. CI, confidence interval; M-H: Mantel-Haenszel; RA, radial artery; SV, saphenous vein. 
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after the initial disappointing results (21). Conventional 
saphenous vein harvesting has not undergone significant 
refinement since its introduction. When the saphenous vein 
is harvested in the conventional manner it is stripped of its 
surrounding tissues, flushed with heparinized saline and 
manually distended with high pressures. The pressures that 
can easily be obtained with manual distension reach about 
2.5 atmospheres, or 2,000 mmHg (22). These maneuvers 
are detrimental for the quality of saphenous vein grafts 
(15,23). Endoscopic vein harvesting may be considered as a 
major development for saphenous vein grafts in CABG. The 
advantage in terms of wound infection, wound healing, and 
scarring has resulted in the recent adoption of endoscopic 
vein harvesting, although issues have been raised regarding 
the patency of these grafts (24). The ‘no-touch’ technique of 
saphenous vein harvesting was introduced in 1996 and long-
term results are promising (16). However, there remain 
concerns about increased leg-wound infection with ‘no-
touch’ saphenous vein harvesting. Wound complications 
are directly related to the patients’ general condition and 
to the surgical technique. There are other important steps 
besides merely harvesting the vein with a fat pedicle such 
as ultrasonographic Doppler assessment which is used 
to mark the course of the vein. This facilitates the skin 
incision exactly above the vein, reducing soft tissue injury 
and creation of a flap. Besides, it allows selection of the 
best segment suitable for grafting. We recommend closing 
of the wound as soon as possible without leaving any dead 
space. To date, we have used ‘no-touch’ saphenous vein 
grafts in more than 3,000 patients, and, by implementing 
the technique as described previously (25), wound healing 
complications were considerably reduced. An ideal 
saphenous vein conduit would combine minimal risk of 
infection and excellent long-term performance. Therefore, 
to achieve a wide adoption of the technique a minimally 
invasive technique for harvesting the ‘no-touch’ saphenous 
vein grafts needs to be developed.
During the past decade there has been an almost 30% 
decline in CABG procedures in the United States, despite 
the supporting evidence for its use. Great advances in 
percutaneous coronary intervention was partially driven 
by the poor outcome when using saphenous vein grafts. 
However, ‘no-touch’ saphenous vein grafts are excellent 
conduits and, when used for CABG, ‘no-touch’ saphenous 
vein harvesting should be made a quality indicator. We 
would suggest, for those surgeons who are proponents of 
arterial conduits, that they firstly choose the target vessels 
that are suitable for arterial conduits, and then, if necessary, 
that they use ‘no-touch’ saphenous vein grafts for the 
remaining targets.
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